This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Fresenius Medical Care's Centenarian Patients Are A Testament To Success Of Dialysis Treatments

The nation’s leading network of dialysis facilities is recognizing more than 25 patients across the nation who will be 100 years or older in 2012 and are still leading healthy, fulfilling lives without their kidney function. A healthy lifestyle has helped these dialysis patients reach the century mark in their lives.

Modern dialysis treatments are giving patients with kidney failure a better chance than ever to maintain a healthy, rewarding lifestyle for many years. Patient commitment to their treatment plan and to making changes in their lifestyle that address diet and exercise habits are important factors in doing well on dialysis. Some of Fresenius Medical Care North America's (FMCNA) centenarian patients have been on dialysis for many years. The company honors approximately 350 long-time patients annually with its Quarter Century Patient Recognition Program, which recognizes patients who have dedicated themselves to their treatment for 25 years or more.

One of the reasons that patients can live longer on dialysis today is that there are more treatment options available, and FMCNA is committed to offering a full range of services to its patients. The company offers free education sessions through its Treatment Options Program (TOPs), to educate patients about all available treatments for kidney failure, and encourages them to find the therapy that best suits their lifestyle and personal needs.

"Our number one goal is to provide the best quality care possible to help patients live a better life on dialysis. Seeing patients reach 100 years of age is extremely rewarding for our company and staff," said Dugan W. Maddux MD, FACP, Vice President, Chronic Kidney Disease Initiatives at FMCNA.

While dialysis has been widely available since the mid-1970s, there have been significant technological advances that have led to the sophisticated equipment used today. Fresenius Medical Care has more than 30 years of experience in research, development and manufacturing of dialysis technology, and today's equipment is able to clean blood enough to allow a stable life on dialysis.

Most long-term dialysis patients attribute their success to adhering to their treatments, eating healthy, exercising regularly, and maintaining an active lifestyle. Patients who understand their condition and stay on track with their treatment program are much more likely to achieve good results with dialysis. Many long-term dialysis patients are also independent and self-reliant people, who maintain a positive attitude and want to live as normal a life as possible with their condition.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%
YHOO $36.01 -1.42%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs